NCT04905420View on ClinicalTrials.gov

The Impact of PCCM on Healthcare Among Asthma or Chronic Obstructive Pulmonary Disease (COPD) or Asthma-COPD Overlap Patients

CompletedOBSERVATIONAL
Enrollment

288,538

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

June 12, 2023

Study Completion Date

June 12, 2023

Conditions
AsthmaCOPDAsthma-COPD Overlap
Trial Locations (1)

Unknown

Tianjin Chest Hospital, Tianjin

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY